AI Verdict
RIGL has stronger fundamentals based on our AI analysis.
RIGL vs RHEPB Fundamental Comparison
| Metric | RIGL | RHEPB |
|---|---|---|
| Revenue | $294.3M | $53.2M |
| Net Income | $367.0M | $3.0M |
| Net Margin | 124.7% | 5.7% |
| ROE | 93.8% | 872.5% |
| ROA | 71.5% | 4.5% |
| Current Ratio | 2.42x | 0.67x |
| Debt/Equity | 0.13x | 123.65x |
| EPS | $19.48 | $1.09 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
RIGL vs RHEPB: Frequently Asked Questions
Is RIGL or RHEPB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), RIGL has stronger fundamentals. RIGL is rated HOLD (68% confidence) while RHEPB is rated STRONG SELL (88% confidence). This is not investment advice.
How does RIGL compare to RHEPB fundamentally?
RIGEL PHARMACEUTICALS INC has ROE of 93.8% vs REGIONAL HEALTH PROPERTIES, INC's 872.5%. Net margins are 124.7% vs 5.7% respectively.
Which stock pays higher dividends, RIGL or RHEPB?
RIGL has a dividend yield of N/A or no dividend while RHEPB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in RIGL or RHEPB for long term?
For long-term investing, consider that RIGL has HOLD rating with 68% confidence, while RHEPB has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about RIGL vs RHEPB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For RIGL vs RHEPB, the AI consensus favors RIGL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.